WH
ELV icon

Willner & Heller’s Elevance Health ELV Stock Holding History

Willner & Heller’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$428K Buy
1,107
+5
+0.5% +$1.85K 0.27% 105
2026
Q1 		$323K Buy
1,102
+6
+0.5% +$1.97K 0.24% 123
2025
Q4 		$384K Buy
1,096
+6
+0.6% +$2.03K 0.28% 106
2025
Q3 		$352K Sell
1,090
-809
-43% -$252K 0.27% 109
2025
Q2 		$739K Sell
1,899
-47
-2% -$18.9K 0.62% 48
2025
Q1 		$847K Sell
1,946
-146
-7% -$58.6K 0.78% 34
2024
Q4 		$772K Buy
2,092
+95
+5% +$39.8K 0.68% 43
2024
Q3 		$1.04M Buy
1,997
+6
+0.3% +$3.21K 0.93% 30
2024
Q2 		$1.08M Buy
1,991
+6
+0.3% +$3.17K 1.03% 24
2024
Q1 		$1.03M Sell
1,985
-54
-3% -$26.9K 1.02% 29
2023
Q4 		$962K Buy
+2,039
New +$943K 1.07% 27
2022
Q4 		$1.07M Sell
2,090
-50
-2% -$25.4K 1.52% 12
2022
Q3 		$972K Buy
2,140
+17
+0.8% +$8.13K 1.57% 13
2022
Q2 		$1.02M Buy
2,123
+47
+2% +$23.3K 1.59% 13
2022
Q1 		$963K Buy
2,076
+5
+0.2% +$2.29K 1.18% 19
2021
Q4 		$772K Buy
+2,071
New +$871K 1.03% 24

Other funds holding ELV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MIHAS
Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PAS
Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return

Willner & Heller's ELV Position: Q2 2026 in Review

Willner & Heller increased its Elevance Health (ELV) stake by 0.45% in Q2 2026, buying an estimated $1.85K and bringing the position to 1,107 shares worth $428K. The position accounts for 0.27% of the portfolio, ranked #105.

Willner & Heller first reported a position in ELV in Q4 2021 and has held it in 16 quarters since. The position peaked at $1.08M in Q2 2024. 222 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Willner & Heller held 1,107 shares of Elevance Health worth $428K as of Q2 2026.
  • Willner & Heller bought 5 Elevance Health shares in Q2 2026, an estimated $1.85K.
  • Elevance Health made up 0.27% of Willner & Heller's portfolio in Q2 2026, its #105 holding.
  • Willner & Heller first reported a position in Elevance Health in Q4 2021 and has held it in 16 quarters since.
  • Willner & Heller's Elevance Health position peaked at $1.08M in Q2 2024.
  • 222 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Willner & Heller's 13F filing for Q2 2026, filed 7 Jul 2026.